Status:

RECRUITING

Growth Hormone Replacement Therapy for Retried Professional Football Players

Lead Sponsor:

Center for Neurological Studies

Collaborating Sponsors:

Novo Nordisk A/S

Conditions:

TBI (Traumatic Brain Injury)

Concussion, Brain

Eligibility:

MALE

18-76 years

Phase:

PHASE2

Brief Summary

This is a randomized, double-blind, placebo-controlled, parallel-group trial with an open-label extension to evaluate the efficacy of growth hormone (GH) on cognitive functions of retired professional...

Detailed Description

GHD is the most common anterior pituitary abnormality after traumatic brain injury (TBI). It can occur as a result of either direct pituitary or indirect hypothalamic injury. Sports-related repetitive...

Eligibility Criteria

Inclusion

  • The subject is willing to provide a signed and dated informed consent indicating that he understands the purpose and procedures required for the study and is willing to participate in the study.
  • Former NFL player
  • At least one year since retirement from football
  • Less than 76 years of age
  • Diagnosis of GHD on clinical grounds by a neurologist and an endocrinologist GHD

Exclusion

  • History of pre-existing brain disease other than concussion or TBI
  • History of a premorbid disabling condition that interferes with outcome assessments
  • Contraindication to GH therapy
  • Type I and II Diabetes mellitus
  • Active malignant disease
  • Acute critical illness, heart failure, or acute respiratory failure
  • Subjects who are deficient in cortisol, testosterone or thyroid at screening will be excluded until hormone abnormalities have been corrected.

Key Trial Info

Start Date :

October 8 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2026

Estimated Enrollment :

42 Patients enrolled

Trial Details

Trial ID

NCT04121780

Start Date

October 8 2019

End Date

September 1 2026

Last Update

February 8 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Center for Neurolgoical Studies (CNS)

Dearborn, Michigan, United States, 48126

Growth Hormone Replacement Therapy for Retried Professional Football Players | DecenTrialz